Funginix Anti-fungal Treatment Ointment
NDC Package 71229-102-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Funginix Anti-fungal Treatment (undecylenic acid) ointment is for the cure of most ringworm (tinea corporis) and athlete’s foot (tinea pedis). This formulation utilizes a ointment delivery system. Marketed by The Sisquoc Healthcare Corporation, this product is identified by NDC 71229-102 and is authorized under FDA application M005.

Identification & Billing

NDC Package Code
71229-102-11
Package Description
30 mL in 1 TUBE
Product Code
71229-102
11-Digit Billing Format
71229010211

Clinical Specifications

Proprietary Name
Funginix Anti-fungal Treatment
Non-Proprietary Name
Undecylenic Acid
Substance Name
Undecylenic Acid
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
UNDECYLENIC ACID 10 g/100mL
Usage Information
For the cure of most ringworm (tinea corporis) and athlete’s foot (tinea pedis). For relief of itching, scaling, cracking, burning, redness,  soreness, irritation and discomforts which may accompany these conditions. Clean the affected area with soap and warm water and dry thoroughly. Apply a thin layer of FUNGINIX over the affected area twice daily (morning and night), or as directed by a physician. Allow 3-5 minutes for the solution to penetrate the skin and absorb fully into the surrounding tissue. FUNGINIX should be applied to cuticles, around nail edges and under nail tips where reachable with the applicator brush. This product is not intended to, nor will it, penetrate hard nail surfaces. For athlete’s foot, pay special attention to spaces between toes; wear well ����itting, ventilated shoes and change shoes and socks at least once daily. For athlete’s foot and ringworm, use daily for 4 weeks. If condition persists longer, consult a doctor. Intended for use by normally healthy adults only. Persons under 18 years of age or those with highly sensitive or allergic skin should use only as directed by a doctor.

Regulatory & Marketing

Labeler Name
The Sisquoc Healthcare Corporation
Product Type
Human Otc Drug
FDA Application #
M005
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-25-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71229-102-11 identifies a specific commercial package of 30 ml in 1 tube of Funginix Anti-fungal Treatment, a human over the counter drug labeled by The Sisquoc Healthcare Corporation. This ointment is formulated for topical use and contains undecylenic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Sisquoc Healthcare Corporation on March 25, 2019. The current certification is valid through December 31, 2026.

How is this The Sisquoc Healthcare Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71229010211. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71229-102-11
11-Digit CMS (5-4-2)
71229-0102-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.